Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1954 2
1960 1
1961 2
1962 3
1963 2
1965 2
1966 4
1967 1
1970 2
1971 7
1972 3
1973 1
1974 3
1975 1
1976 1
1977 1
1979 1
1980 1
1981 1
1984 4
1985 1
1987 3
1989 1
1992 2
1993 4
1994 2
1995 1
2001 1
2002 4
2003 2
2004 3
2005 2
2006 5
2007 5
2008 4
2009 3
2010 2
2011 2
2013 1
2014 2
2015 3
2016 1
2017 1
2018 1
2019 3
2020 7
2021 4
2022 1
2024 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

113 results

Results by year

Filters applied: . Clear all
Page 1
Natalizumab update.
Sweet BV. Sweet BV. Am J Health Syst Pharm. 2007 Apr 1;64(7):705-16. doi: 10.2146/ajhp060588. Am J Health Syst Pharm. 2007. PMID: 17384355 Review.
Robust estimation of bacterial cell count from optical density.
Beal J, Farny NG, Haddock-Angelli T, Selvarajah V, Baldwin GS, Buckley-Taylor R, Gershater M, Kiga D, Marken J, Sanchania V, Sison A, Workman CT; iGEM Interlab Study Contributors. Beal J, et al. Commun Biol. 2020 Sep 17;3(1):512. doi: 10.1038/s42003-020-01127-5. Commun Biol. 2020. PMID: 32943734 Free PMC article.
Oral acetylcysteine for neuropsychiatric disorders.
Racz R, Sweet BV, Sohoni P. Racz R, et al. Among authors: sweet bv. Am J Health Syst Pharm. 2015 Jun 1;72(11):923-6, 928-9. doi: 10.2146/ajhp140732. Am J Health Syst Pharm. 2015. PMID: 25987686 Review. No abstract available.
Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis.
Fox RJ, Coffey CS, Conwit R, Cudkowicz ME, Gleason T, Goodman A, Klawiter EC, Matsuda K, McGovern M, Naismith RT, Ashokkumar A, Barnes J, Ecklund D, Klingner E, Koepp M, Long JD, Natarajan S, Thornell B, Yankey J, Bermel RA, Debbins JP, Huang X, Jagodnik P, Lowe MJ, Nakamura K, Narayanan S, Sakaie KE, Thoomukuntla B, Zhou X, Krieger S, Alvarez E, Apperson M, Bashir K, Cohen BA, Coyle PK, Delgado S, Dewitt LD, Flores A, Giesser BS, Goldman MD, Jubelt B, Lava N, Lynch SG, Moses H, Ontaneda D, Perumal JS, Racke M, Repovic P, Riley CS, Severson C, Shinnar S, Suski V, Weinstock-Guttman B, Yadav V, Zabeti A; NN102/SPRINT-MS Trial Investigators. Fox RJ, et al. N Engl J Med. 2018 Aug 30;379(9):846-855. doi: 10.1056/NEJMoa1803583. N Engl J Med. 2018. PMID: 30157388 Free PMC article. Clinical Trial.
Abatacept.
Sweet BV. Sweet BV. Am J Health Syst Pharm. 2006 Nov 1;63(21):2065-77. doi: 10.2146/ajhp060200. Am J Health Syst Pharm. 2006. PMID: 17057043
Alternative therapies. Wormwood.
Skyles AJ, Sweet BV. Skyles AJ, et al. Among authors: sweet bv. Am J Health Syst Pharm. 2004 Feb 1;61(3):239-42. doi: 10.1093/ajhp/61.3.239. Am J Health Syst Pharm. 2004. PMID: 14986553 Review. No abstract available.
Drug shortages: a complex health care crisis.
Fox ER, Sweet BV, Jensen V. Fox ER, et al. Among authors: sweet bv. Mayo Clin Proc. 2014 Mar;89(3):361-73. doi: 10.1016/j.mayocp.2013.11.014. Mayo Clin Proc. 2014. PMID: 24582195 Review.
Hawthorn: pharmacology and therapeutic uses.
Rigelsky JM, Sweet BV. Rigelsky JM, et al. Among authors: sweet bv. Am J Health Syst Pharm. 2002 Mar 1;59(5):417-22. doi: 10.1093/ajhp/59.5.417. Am J Health Syst Pharm. 2002. PMID: 11887407 Review.
113 results